Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 29466156

Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2018 Feb 22
First author
Drilon A

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2018 Feb 22;378(8):763-765. doi: 10.1056/NEJMe1716821.
    note
    Source null
    related pmid
    29466154
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2018 Apr;19(4):e187. doi: 10.1016/S1470-2045(18)30190-6.
    note
    Source null
    related pmid
    29503244
    relationship
    Comment in
  3. citation
    Nat Rev Clin Oncol. 2018 May;15(5):264. doi: 10.1038/nrclinonc.2018.40.
    note
    Source null
    related pmid
    29532798
    relationship
    Comment in
  4. citation
    Ann Transl Med. 2019 Jul;7(Suppl 3):S155. doi: 10.21037/atm.2019.06.41.
    note
    Source null
    related pmid
    31576362
    relationship
    Comment in

Authors and identifiers

  1. name
    Drilon A
    type
    Author
  2. name
    Laetsch TW
    type
    Author
  3. name
    Kummar S
    type
    Author
  4. name
    DuBois SG
    type
    Author
  5. name
    Lassen UN
    type
    Author
  6. name
    Demetri GD
    type
    Author
  7. name
    Nathenson M
    type
    Author
  8. name
    Doebele RC
    type
    Author
  9. name
    Farago AF
    type
    Author
  10. name
    Pappo AS
    type
    Author
  11. name
    Turpin B
    type
    Author
  12. name
    Dowlati A
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Drilon A
    type
    Author
  2. name
    Laetsch TW
    type
    Author
  3. name
    Kummar S
    type
    Author
  4. name
    DuBois SG
    type
    Author
  5. name
    Lassen UN
    type
    Author
  6. name
    Demetri GD
    type
    Author
  7. name
    Nathenson M
    type
    Author
  8. name
    Doebele RC
    type
    Author
  9. name
    Farago AF
    type
    Author
  10. name
    Pappo AS
    type
    Author
  11. name
    Turpin B
    type
    Author
  12. name
    Dowlati A
    type
    Author
bibliography ids
  1. nci-bib-587ffaadf3802c1b191a40dd
book metadata
content sha256
a057090be2e654c66034f64d2fac68aa3e077e3422fadcf0ae02e76f8f17bea1
document type
citation
dois
  1. 10.1056/NEJMoa1714448
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:29466156
immutable id
pubmed:29466156@a057090be2e654c66034f64d2fac68aa3e077e3422fadcf0ae02e76f8f17bea1
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
8
name
The New England journal of medicine
nlm unique id
0255562
pages
731-739
volume
378
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2018 Feb 22;378(8):763-765. doi: 10.1056/NEJMe1716821.
    note
    Source null
    related pmid
    29466154
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2018 Apr;19(4):e187. doi: 10.1016/S1470-2045(18)30190-6.
    note
    Source null
    related pmid
    29503244
    relationship
    Comment in
  3. citation
    Nat Rev Clin Oncol. 2018 May;15(5):264. doi: 10.1038/nrclinonc.2018.40.
    note
    Source null
    related pmid
    29532798
    relationship
    Comment in
  4. citation
    Ann Transl Med. 2019 Jul;7(Suppl 3):S155. doi: 10.21037/atm.2019.06.41.
    note
    Source null
    related pmid
    31576362
    relationship
    Comment in
outcomes validated
false
pmid
29466156
provenance
batch id
ec9444d0f4cade22eb9f
provider
NCBI PubMed ESummary
record sha256
354612023d154eb312b4b0884287ced4e6202132fc95032e24ede39806d78b72
response sha256
6eef0d8cc09b77e73af656f6390cc734befb84fbc4c229b886e81e5d95bece31
retrieved at
2026-09-09T23:47:30.975610+00:00
publication date
display
2018 Feb 22
precision
day
year
2018
publication types
  1. Clinical Trial, Phase I
  2. Clinical Trial, Phase II
  3. Journal Article
  4. Research Support, N.I.H., Extramural
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/29466156/
title
Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children.

Preserved source evidence · Independent clinical review pending · Not medical advice